Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Millennium discovers new antibiotic from fungal culture

March 23, 1998

Merck & Co. reveals new prodrugs of fibrinogen receptor antagonists

March 23, 1998

Inhibitors of CETP for hyperlipidemia/atherosclerosis in development at Bayer

March 23, 1998

Agents for VRE prepared at Lilly

March 23, 1998

Cyclic sulfones synthesized at Pfizer inhibit MMPs and TNF production

March 23, 1998

Antiinflammatory agents with a good safety profile disclosed by Taisho

March 23, 1998

Selective functional AMPA antagonists patented by ADIR

March 20, 1998

Lilly reveals new series of hypoglycemic/hypolipidemic compounds

March 20, 1998

New antineoplastic glutamic acid derivatives synthesized at Princeton

March 20, 1998

Antiplatelet agents reported by researchers at Nippon Steel

March 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...